FirstRand Bank Ltd 2025-25.03.30 NNETNC on Novo Nord Br/-B Exchange Traded Product

FirstRand Bank Ltd 2025-25.03.30 NNETNC on Novo Nord Br/-B Exchange Traded Product is offered by FirstRand, a leading player in the field of passive investments.

European investors may incur additional costs for currency exchange and transaction fees.

No, FirstRand Bank Ltd 2025-25.03.30 NNETNC on Novo Nord Br/-B Exchange Traded Product does not comply with the EU UCITS investor protection directives.

FirstRand Bank Ltd 2025-25.03.30 NNETNC on Novo Nord Br/-B Exchange Traded Product tracks the performance of the Novo Nordisk A/S Class B - USD - Benchmark Price Return.

FirstRand Bank Ltd 2025-25.03.30 NNETNC on Novo Nord Br/-B Exchange Traded Product is domiciled in ZA.

The fund was launched on 3/24/2025.

The FirstRand Bank Ltd 2025-25.03.30 NNETNC on Novo Nord Br/-B Exchange Traded Product mainly invests in Healthcare companies.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.